Paulson John 4
Research Summary
AI-generated summary
Bausch Health (BHC) Director John Paulson Receives RSU Award
What Happened
John Paulson, a director of Bausch Health Companies Inc. (BHC), was granted 45,871 restricted share units (RSUs) on 2026-05-22. The award shows an acquisition price of $0.00 (awarded, not purchased) and has a grant-date value of $250,000. The RSUs vest on the date immediately preceding the issuer’s next Annual Meeting of Shareholders and will be settled in common shares.
Key Details
- Transaction type: Award/Grant (A) of 45,871 RSUs on 2026-05-22; filing dated 2026-05-26.
- Price/value: $0.00 per RSU (awarded); grant-date value = $250,000.
- Vesting/settlement: Vest immediately before next annual meeting; settled in common shares.
- Shares owned after transaction: Not specified in the filing.
- Footnote: RSUs were granted to non-employee directors per the company’s director grant schedule (granted on the third business day after election).
- Beneficial ownership note: John Paulson is identified as the controlling person of Paulson Capital Inc.; he may be deemed an indirect beneficial owner of securities held directly by certain investment funds (filing includes standard disclaimer).
Context
This was an equity award to a non-employee director (routine compensation), not an open-market purchase or sale. Awards like RSUs are compensation and do not necessarily indicate a personal cash investment or sale decision by the director.